Clinical Lab Chat Clinical Lab Products

In a shift from talking about clinical diagnostics, this episode of Clinical Lab Chat focuses on how laboratory listeners can manage stress. With the help of Brent Franson, founder and CEO of Most Days, CLP’s director of business intelligence, Chris Wolski, discusses ways you can manage stress, including:
Making the “little things”: sleep, exercise, and diet good habits.Why taking a hard look at the Big Things—work, relationships, and where you live—will help you get to the root cause and minimize stressTwo practical steps laboratorians and pathologists can take to manage the regular stress of their stressful jobs.The first step you can take to prepare you to address the Big Things in your life

After being declared eradicated in the U.S. in 2000, measles has been making a comeback in recent years—the current caseload equals the entire number of cases in 2023. In this wide-ranging discussion, CLP’s director of business intelligence, Chris Wolski, and Rodney Rohde, PhD, Regents’ Professor in the Texas State University System, a University Distinguished Professor and Chair for the Medical Laboratory Science (MLS) Program in the College of Health Professions at Texas State University, discuss:
The causes of the measles outbreakWhy measles should be taken seriously by the publicThe tension between individual rights and public healthHow and why measles is diagnosedThe long-term effects of measlesHow laboratory professionals can be advocates for good health information

In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, sits down with OpentronsCEO Jonathan Brennan-Badal to discuss all things robotic. In their wide-ranging discussion, they touch on:
The trends in clinical laboratory robotsHow to make a use case for adding robots to your labHow to plan for automationThe challenges with laboratory roboticsWhat to expect in the next 5 to 10 years

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology, and how it is delivering on the promise of Theranos’ failed technology, what it means for access, and how it could be a major paradigm shift in the way patients’ blood specimens are collected and the form in which labs receive them. 

In the latest edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Sara Naseri, MD, co-founder and CEO of women’s health company, Qvin (qvin.com), about the Q-Pad, an FDA-cleared menstrual pad designed to collect blood to be processed for diagnostic purposes. In this wide-ranging discussion, Naseri and Wolski discuss how she came up with this unique, out-of-the-box idea; how the company plans to overcome the taboos associated with menstruation; how the Q-pad will improve access to health care; and the company’s plans for the future.

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific. 
 
Some ideas the two discussed during their conversation include:
The significance of personalized medicine, and how marrying proteomics with genomics can better support individual health journeys.How precision medicine could change the relationship between the clinical lab and physicians.Ways Thermo Fisher’s Orbitrap Astral Mass Spectrometer supports lab clinicians.Current challenges and predictions in the space.